It is clear from the reviews by McGiff and Quilley (1981) and ourselves (Trippodo and Frohlich, 1981) that we have no major inconsistency in our thinking. The reviews are in agreement that essential hypertension is a multifactorial, genetically related disease of man that is expressed by a dysregulation of the mechanisms that control arterial pressure at normal levels.
In our review we have made a case for the need for an experimental model of hypertension that: is genetic; is slow in progression of vascular disease; involves no gross defect in renal, endocrine, or neural mechanisms; and, although subtle alterations may occur, these defects should permit adaptations in the involved systems.
Both reviews presuppose that the defects in essential hypertension are at present unknown. Since this is so, it would indeed be presumptuous to advocate that any one existing model in which the participating pressor (or depressor) mechanism(s) is unknown is that one experimental analogue of clinical essential hypertension. Nevertheless, to understand the problem more completely does require controlled experimental studies that may not be feasible in man. At present, the spontaneously hypertensive rat (SHR) is the only naturally occurring model that is generally available to explore this comparison.
The evidence cited in our review more heavily favors participation of neural mechanisms in the SHR, although we have acknowledged the possibilities that other factors are also involved. That prostaglandins do not seem to be a major physiological system in the rat is not particularly disturbing. Perhaps if we learn how the rat survives in the presence of this seemingly unusual prostaglandin system, we might better understand how it may be altered in a normotensive or a hypertensive state, and we would comprehend yet another aspect of the mechanisms involved in arterial pressure homeostasis. Thus, to negate studying the problem because we may be comparing "two unknowns" is not quite valid. Much is known physiologically about the patient with essential hypertension, and much is known about the SHR; neither is a pure "unknown" or "black box." Knowledge about both in relationship to other systems and models helps in extending our overall comprehension of the mechanisms that regulate arterial pressure.
The young disease, that must subdue at length, Grows with his growth, and strengthens with his strength*
Our academic and investigative interest has been in the progressive hemodynamic alterations associated with the development, progression, and maintenance of hypertension. Through our SHR studies we have seen the early state of cardiac adaptation (hyperfunction) that is associated with both arteriolar and venular constriction. We have learned that left ventricular adaptation and performance subserve normal systemic and regional blood flow distribution. And we have learned that impaired myocardial performance is a late feature of the older SHR that precedes overt left ventricular failure. These findings are remarkably similar to those in man with progressively increasing total peripheral resistance associated with essential hypertension.
That essential hypertension is multifactorial, that at times it may be manifest by excessive participation of neural, renopressor, or other mechanisms only means that various models of genetic hypertension are necessary to understand participation of each of the pressor (and depressor) mechanisms in naturally occurring hypertensive disease. To this end the SHR is a suitable model for essential hypertension. Hopefully, other models will become more generally available to our scientific population. Until then- 
